Jushi Holdings Inc. (JUSH): Revenue

Annual figures by period end, from SEC filings.

$262.91M
Year ended 2025-12-31
$271.75M
Trailing 12 months to 2026-06-30
-2.6%
3-year compound annual growth
+26.6%
5-year compound annual growth
$284.28M2020-12-31: $80.77M2021-12-31: $209.29M2022-12-31: $284.28M2023-12-31: $269.44M2024-12-31: $257.52M2025-12-31: $262.91M$262.91M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$262.91M+2.1%2026-03-31, From 2025-01-01
2024-12-31$257.52M-4.4%2026-03-31, From 2024-01-01
2023-12-31$269.44M-5.2%2026-03-31, From 2023-01-01
2022-12-31$284.28M+35.8%2024-04-01, From 2022-01-01
2021-12-31$209.29M+159.1%2024-04-01, From 2021-01-01
2020-12-31$80.77Mn/a2023-04-18, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Jushi Holdings Inc. (JUSH)2025-12-31$262.91M+2.1%
biote Corp. (BTMD)2025-12-31$192.22M-2.5%
Glass House Brands Inc. (GLAS)2025-12-31$181.98M-9.4%
Marimed Inc. (MRMD)2025-12-31$159.83M+1.3%
Cronos Group Inc. (CRON)2025-12-31$146.59M+24.6%
Natural Alternatives International Inc (NAII)2026-06-30$142.51M+9.7%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$500.58M-10.9%
Niagen Bioscience, Inc. (NAGE)2025-12-31$129.42M+29.9%
Mannatech Inc (MTEX)2025-12-31$108.04M-8.3%

Compare JUSH, BTMD, GLAS, MRMD side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗